[1] |
ARROYO V, MOREAU R, JALAN R. Acute-on-chronic liver failure[J]. N Engl J Med, 2020, 382(22): 2137-2145. DOI: 10.1056/NEJMra1914900.
|
[2] |
LISMAN T, PORTE RJ. Mechanisms of platelet-mediated liver regeneration[J]. Blood, 2016, 128(5): 625-629. DOI: 10.1182/blood-2016-04-692665.
|
[3] |
ARYAL B, YAMAKUCHI M, SHIMIZU T, et al. Therapeutic implication of platelets in liver regeneration -hopes and hues[J]. Expert Rev Gastroenterol Hepatol, 2018, 12(12): 1219-1228. DOI: 10.1080/17474124.2018.1533813.
|
[4] |
TAKAHASHI K, LIANG C, ODA T, et al. Platelet and liver regeneration after liver surgery[J]. Surg Today, 2020, 50(9): 974-983. DOI: 10.1007/s00595-019-01890-x.
|
[5] |
Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
|
[6] |
JIE Y, GONG J, XIAO C, et al. Low platelet to white blood cell ratio indicates poor prognosis for acute-on-chronic liver failure[J]. Biomed Res Int, 2018, 2018: 7394904. DOI: 10.1155/2018/7394904.
|
[7] |
XU X, HOU Z, XU Y, et al. The dynamic of platelet count as a novel and valuable predictor for 90-day survival of hepatitis B virus-related acute-on-chronic liver failure patients[J]. Clin Res Hepatol Gastroenterol, 2021, 45(2): 101482. DOI: 10.1016/j.clinre.2020.06.008.
|
[8] |
GUO J, GONG ZJ, SHI CX. Research progress on hepatitis B virus related acute-on-chronic liver failure with infections[J/CD]. Chin J Liver Dis(Electronic Edition), 2022, 14(3): 5-8. DOI:
郭金, 龚作炯, 石春霞. 乙型肝炎病毒相关慢加急性肝衰竭合并感染研究进展[J/CD]. 中国肝脏病杂志(电子版), 2022, 14(3): 5-8. DOI:
|
[9] |
DUSEJA A, SINGH SP. Toward a better definition of acute-on-chronic liver failure[J]. J Clin Exp Hepatol, 2017, 7(3): 262-265. DOI: 10.1016/j.jceh.2017.05.002.
|
[10] |
GAO XY, CHEN L, GAN JH. Value of Model for End-Stage Liver Disease score combined with platelet-to-white blood cell ratio in predicting the prognosis of patients with hepatitis B virus-associated acute-on-chronic liver failure[J]. J Clin Hepatol, 2021, 37(5): 1070-1074. DOI: 10.3969/j.issn.1001-5256.2021.05.019.
高心怡, 陈丽, 甘建和. MELD评分联合血小板/白细胞比值对HBV相关慢加急性肝衰竭患者预后的预测价值[J]. 临床肝胆病杂志, 2021, 37(5): 1070-1074. DOI: 10.3969/j.issn.1001-5256.2021.05.019.
|
[11] |
SARIN SK, CHOUDHURY A, SHARMA MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update[J]. Hepatol Int, 2019, 13(4): 353-390. DOI: 10.1007/s12072-019-09946-3.
|
[12] |
SHI Y, YANG Y, HU Y, et al. Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults[J]. Hepatology, 2015, 62(1): 232-242. DOI: 10.1002/hep.27795.
|
1. | 涂雨落,孙克伟. 基于“阳黄-阴阳黄-阴黄”辨证论治模式治疗HBV相关慢加急性肝衰竭的临床疗效分析. 中国中西医结合消化杂志. 2024(03): 195-202 . ![]() | |
2. | 张冬梅,李婷,陈素玲. FIB-4、总胆红素及GPRI水平与肝癌切除术后肝功能衰竭并发症的相关性. 临床和实验医学杂志. 2024(08): 830-833 . ![]() | |
3. | 韩肇丹,许军,李芃芃,赵卫娟. AARC-ACLF评分联合NLR对HBV相关慢加急性肝衰竭短期预后的评估价值. 肝脏. 2024(05): 538-541 . ![]() | |
4. | 匡竞,滕双芩,申彤彤,闫怡然,王玮,申川,赵彩彦. 肝硬化门脉性肺动脉高压危险因素分析及预测模型构建. 临床肝胆病杂志. 2024(09): 1802-1806 . ![]() | |
5. | 张仕华,柏承志,李春燕,徐理茂,徐华谦,汤善宏. 老年HBV相关慢加急性肝衰竭预后的危险因素及风险预测列线图模型构建. 临床肝胆病杂志. 2024(10): 1976-1984 . ![]() | |
6. | 马万龙,马玉,王伟红,丁向春,焦运,刘帅伟,海龙. 慢加急性肝衰竭患者预后生存分析. 中华肝脏病杂志. 2023(10): 1051-1055 . ![]() |